Himanshi Chawla

661 citations
11 papers · 213 indexed · h-index 8
Topics
HIV Research and Treatment (7 papers)HIV/AIDS drug development and treatment (5 papers)SARS-CoV-2 and COVID-19 Research (3 papers)

In The Last Decade

Himanshi Chawla

10 papers receiving 212 citations

Peers

Himanshi Chawla
Comparison fields: 5 of 39
  • Infectious Diseases 122
  • Epidemiology 71
  • Virology 68
  • Molecular Biology 56
  • Immunology 46
Replace Nadejda Valiaeva with:
Nadejda Valiaeva United States
Aprille Rapista United States
Elias Harkins United States
Meghan Garrett United States
Kevin J. Selva Australia
Sven Blokland Netherlands
Ralf Duerr United States
Heather Arendt United States
Tatsiana Bylund United States
Isabel Scholz United States
Himanshi Chawla relative to Nadejda Valiaeva United States Nadejda Valiaeva's profile →
Citations per field
00.5×2.9×
Nadejda Valiaeva · 1×
Citations per year

Countries citing papers authored by Himanshi Chawla

Since Specialization
Citations

This map shows the geographic impact of Himanshi Chawla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Himanshi Chawla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Himanshi Chawla more than expected).

Fields of papers citing papers by Himanshi Chawla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Himanshi Chawla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Himanshi Chawla. The network helps show where Himanshi Chawla may publish in the future.

Co-authorship network of co-authors of Himanshi Chawla

This figure shows the co-authorship network connecting the top 25 collaborators of Himanshi Chawla. A scholar is included among the top collaborators of Himanshi Chawla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Himanshi Chawla. Himanshi Chawla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 8
3 30
4 16
5 51
6 21
7 4
8 6
9 11
10 27
11 39

About Himanshi Chawla

Himanshi Chawla is a scholar working on Virology, Infectious Diseases and Immunology, having authored 11 papers that have together received 213 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Virology (68 citations), Infectious Diseases (122 citations) and Ophthalmology (29 citations). Himanshi Chawla has collaborated with scholars based in United Kingdom, India and United States. Frequent co-authors include Max Crispin, Joel D. Allen, Maddy L. Newby, Yasunori Watanabe, Elisa Fadda, Jenny Munro, Alan R. Watson, M J Ford, Sanjeev Kumar and S. K. Kabra. Their work appears in journals such as Nature Communications, Journal of Molecular Biology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026